Paradoxical embolism after surgery for breast cancer: a case report

by Zhimin Yu, Heran Deng, Jie Wang, Junyao Xu
Published 2020-07-01

Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status.

by Kai Mao, Yaping Yang, Wei Wu, Shi Liang, Heran Deng, Jieqiong Liu
Published 2017-01-01

Clinical predictive models for chemotherapy-induced febrile neutropenia in breast cancer patients: a validation study.

by Kai Chen, Xiaolan Zhang, Heran Deng, Liling Zhu, Fengxi Su, Weijuan Jia, Xiaogeng Deng
Published 2014-01-01

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: study protocol for a randomized pilot trial

by Wei Wu, Heran Deng, Nanyan Rao, Na You, Yaping Yang, Minghui Cao, Jieqiong Liu
Published 2017-10-01

Reduced Let-7a Is Associated with Chemoresistance in Primary Breast Cancer.

by Jiannan Wu, Shunrong Li, Weijuan Jia, Heran Deng, Kai Chen, Liling Zhu, Fengyan Yu, Fengxi Su
Published 2015-01-01

Multicentre, randomised, open-label, non-inferiority trial comparing the effectiveness and safety of ductal lavage versus oral corticosteroids for idiopathic granulomatous mastitis...

by Fengxi Su, Tingting Hu, Shunrong Li, Heng Huang, Hui Huang, Luyuan Tan, Yanbo Chen, Heran Deng, Jiannan Wu, Liling Zhu
Published 2020-10-01

Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer

by Yaping Yang, Ying Wang, Heran Deng, Cui Tan, Qian Li, Zhanghai He, Wei Wei, Enxiang Zhou, Qiang Liu, Jieqiong Liu
Published 2019-06-01

Neoadjuvant everolimus plus letrozole versus fluorouracil, epirubicin and cyclophosphamide for ER-positive, HER2-negative breast cancer: a randomized pilot trial

by Wei Wu, Jiewen Chen, Heran Deng, Liang Jin, Zhanghai He, Nanyan Rao, Yan Nie, Yandan Yao, Yaping Yang, Fengxi Su, Jieqiong Liu
Published 2021-07-01